Patricia Daly, MD
Psychiatry · Hartford, VTNPI 1578583142
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 88 payments — averaging $4822.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$209K
- Alkermes, Inc.$112K
- Sunovion Pharmaceuticals Inc.$58K
- Sage Therapeutics, LLC$22K
- Avanir Pharmaceuticals, Inc.$12K
- Livanova USA, Inc.$11K
How this compares
$0 in reported general payments places this provider in the 70th percentile of 96 psychiatry providers in Vermont.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 13 | $354 |
| Lorazepam | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Hartford
- Lynn McCormickHartford$0
- Matthew NarleskyBrattleboro$2K
- Jillan SackettShelburne$339
- David AppelBurlington$299
- John MalloyBurlington$250
- Gregoria MarreroBrattleboro$194
- Lisa Catapano FriedmanBennington$175
- Peter JacksonBurlington$132
- Matthew SommonsRutland$123
- Elizabeth JosephBrattleboro$108
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.